nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—CYP2D6—Niacin—atherosclerosis	0.135	0.169	CbGbCtD
Dihydrocodeine—CYP2D6—Simvastatin—atherosclerosis	0.107	0.134	CbGbCtD
Dihydrocodeine—CYP2D6—Lovastatin—atherosclerosis	0.105	0.131	CbGbCtD
Dihydrocodeine—CYP2D6—Pravastatin—atherosclerosis	0.105	0.131	CbGbCtD
Dihydrocodeine—CYP3A4—Ezetimibe—atherosclerosis	0.0732	0.0916	CbGbCtD
Dihydrocodeine—CYP3A4—Rosuvastatin—atherosclerosis	0.0732	0.0916	CbGbCtD
Dihydrocodeine—CYP3A4—Simvastatin—atherosclerosis	0.0681	0.0851	CbGbCtD
Dihydrocodeine—CYP3A4—Pravastatin—atherosclerosis	0.0666	0.0833	CbGbCtD
Dihydrocodeine—CYP3A4—Lovastatin—atherosclerosis	0.0666	0.0833	CbGbCtD
Dihydrocodeine—Hepatic enzyme increased—Rosuvastatin—atherosclerosis	0.00533	0.0315	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00267	0.0158	CcSEcCtD
Dihydrocodeine—Affect lability—Pravastatin—atherosclerosis	0.00258	0.0153	CcSEcCtD
Dihydrocodeine—Urinary retention—Niacin—atherosclerosis	0.00253	0.015	CcSEcCtD
Dihydrocodeine—Mood swings—Pravastatin—atherosclerosis	0.00249	0.0147	CcSEcCtD
Dihydrocodeine—Mental disorder—Rosuvastatin—atherosclerosis	0.00222	0.0131	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00222	0.0131	CcSEcCtD
Dihydrocodeine—Angioedema—Rosuvastatin—atherosclerosis	0.00201	0.0119	CcSEcCtD
Dihydrocodeine—Angiopathy—Ezetimibe—atherosclerosis	0.00191	0.0113	CcSEcCtD
Dihydrocodeine—Immune system disorder—Ezetimibe—atherosclerosis	0.0019	0.0112	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.0019	0.0112	CcSEcCtD
Dihydrocodeine—Mental disorder—Ezetimibe—atherosclerosis	0.00184	0.0109	CcSEcCtD
Dihydrocodeine—Confusional state—Rosuvastatin—atherosclerosis	0.00181	0.0107	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00176	0.0104	CcSEcCtD
Dihydrocodeine—Mental disorder—Simvastatin—atherosclerosis	0.00176	0.0104	CcSEcCtD
Dihydrocodeine—Angioedema—Lovastatin—atherosclerosis	0.00171	0.0101	CcSEcCtD
Dihydrocodeine—Vertigo—Lovastatin—atherosclerosis	0.00168	0.00992	CcSEcCtD
Dihydrocodeine—Angioedema—Ezetimibe—atherosclerosis	0.00167	0.0099	CcSEcCtD
Dihydrocodeine—Angiopathy—Niacin—atherosclerosis	0.00167	0.00989	CcSEcCtD
Dihydrocodeine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00162	0.00955	CcSEcCtD
Dihydrocodeine—Angioedema—Simvastatin—atherosclerosis	0.0016	0.00944	CcSEcCtD
Dihydrocodeine—Vertigo—Simvastatin—atherosclerosis	0.00157	0.00928	CcSEcCtD
Dihydrocodeine—Dry mouth—Lovastatin—atherosclerosis	0.00156	0.0092	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00155	0.00916	CcSEcCtD
Dihydrocodeine—Constipation—Rosuvastatin—atherosclerosis	0.00154	0.00909	CcSEcCtD
Dihydrocodeine—Confusional state—Lovastatin—atherosclerosis	0.00154	0.00909	CcSEcCtD
Dihydrocodeine—Dry mouth—Ezetimibe—atherosclerosis	0.00153	0.00902	CcSEcCtD
Dihydrocodeine—Confusional state—Ezetimibe—atherosclerosis	0.00151	0.00891	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00148	0.00876	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00147	0.0087	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Ezetimibe—atherosclerosis	0.00147	0.00867	CcSEcCtD
Dihydrocodeine—Angioedema—Niacin—atherosclerosis	0.00147	0.00867	CcSEcCtD
Dihydrocodeine—Skin disorder—Ezetimibe—atherosclerosis	0.00145	0.00859	CcSEcCtD
Dihydrocodeine—Angioedema—Pravastatin—atherosclerosis	0.00144	0.00853	CcSEcCtD
Dihydrocodeine—Vertigo—Niacin—atherosclerosis	0.00144	0.00852	CcSEcCtD
Dihydrocodeine—Confusional state—Simvastatin—atherosclerosis	0.00144	0.0085	CcSEcCtD
Dihydrocodeine—Urticaria—Rosuvastatin—atherosclerosis	0.00143	0.00845	CcSEcCtD
Dihydrocodeine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00142	0.00841	CcSEcCtD
Dihydrocodeine—Vertigo—Pravastatin—atherosclerosis	0.00142	0.00839	CcSEcCtD
Dihydrocodeine—Paraesthesia—Lovastatin—atherosclerosis	0.00137	0.00809	CcSEcCtD
Dihydrocodeine—Dyspnoea—Lovastatin—atherosclerosis	0.00136	0.00804	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00136	0.00802	CcSEcCtD
Dihydrocodeine—Paraesthesia—Ezetimibe—atherosclerosis	0.00134	0.00794	CcSEcCtD
Dihydrocodeine—Dry mouth—Niacin—atherosclerosis	0.00134	0.0079	CcSEcCtD
Dihydrocodeine—Dyspnoea—Ezetimibe—atherosclerosis	0.00133	0.00788	CcSEcCtD
Dihydrocodeine—Constipation—Lovastatin—atherosclerosis	0.0013	0.00771	CcSEcCtD
Dihydrocodeine—Confusional state—Pravastatin—atherosclerosis	0.0013	0.00769	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00129	0.00763	CcSEcCtD
Dihydrocodeine—Paraesthesia—Simvastatin—atherosclerosis	0.00128	0.00757	CcSEcCtD
Dihydrocodeine—Constipation—Ezetimibe—atherosclerosis	0.00128	0.00756	CcSEcCtD
Dihydrocodeine—Pruritus—Rosuvastatin—atherosclerosis	0.00127	0.00752	CcSEcCtD
Dihydrocodeine—Skin disorder—Niacin—atherosclerosis	0.00127	0.00752	CcSEcCtD
Dihydrocodeine—Dyspnoea—Simvastatin—atherosclerosis	0.00127	0.00752	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Niacin—atherosclerosis	0.00127	0.00748	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Lovastatin—atherosclerosis	0.00126	0.00743	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00125	0.00737	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00125	0.00737	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Ezetimibe—atherosclerosis	0.00123	0.00728	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00123	0.00728	CcSEcCtD
Dihydrocodeine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00123	0.00728	CcSEcCtD
Dihydrocodeine—Hypotension—Niacin—atherosclerosis	0.00122	0.00723	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00122	0.00723	CcSEcCtD
Dihydrocodeine—Constipation—Simvastatin—atherosclerosis	0.00122	0.00721	CcSEcCtD
Dihydrocodeine—Urticaria—Lovastatin—atherosclerosis	0.00121	0.00716	CcSEcCtD
Dihydrocodeine—Abdominal pain—Lovastatin—atherosclerosis	0.00121	0.00713	CcSEcCtD
Dihydrocodeine—Dizziness—Rosuvastatin—atherosclerosis	0.00119	0.00703	CcSEcCtD
Dihydrocodeine—Urticaria—Ezetimibe—atherosclerosis	0.00119	0.00702	CcSEcCtD
Dihydrocodeine—Abdominal pain—Ezetimibe—atherosclerosis	0.00118	0.00699	CcSEcCtD
Dihydrocodeine—Paraesthesia—Niacin—atherosclerosis	0.00118	0.00695	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Simvastatin—atherosclerosis	0.00118	0.00695	CcSEcCtD
Dihydrocodeine—Dyspnoea—Niacin—atherosclerosis	0.00117	0.0069	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00117	0.00689	CcSEcCtD
Dihydrocodeine—Somnolence—Niacin—atherosclerosis	0.00116	0.00688	CcSEcCtD
Dihydrocodeine—Paraesthesia—Pravastatin—atherosclerosis	0.00116	0.00684	CcSEcCtD
Dihydrocodeine—Dyspnoea—Pravastatin—atherosclerosis	0.00115	0.0068	CcSEcCtD
Dihydrocodeine—Rash—Rosuvastatin—atherosclerosis	0.00113	0.00671	CcSEcCtD
Dihydrocodeine—Dermatitis—Rosuvastatin—atherosclerosis	0.00113	0.0067	CcSEcCtD
Dihydrocodeine—Urticaria—Simvastatin—atherosclerosis	0.00113	0.0067	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Niacin—atherosclerosis	0.00113	0.00668	CcSEcCtD
Dihydrocodeine—Abdominal pain—Simvastatin—atherosclerosis	0.00113	0.00666	CcSEcCtD
Dihydrocodeine—Headache—Rosuvastatin—atherosclerosis	0.00113	0.00666	CcSEcCtD
Dihydrocodeine—Constipation—Pravastatin—atherosclerosis	0.0011	0.00652	CcSEcCtD
Dihydrocodeine—Pruritus—Lovastatin—atherosclerosis	0.00108	0.00638	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Niacin—atherosclerosis	0.00107	0.00633	CcSEcCtD
Dihydrocodeine—Nausea—Rosuvastatin—atherosclerosis	0.00107	0.00632	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Pravastatin—atherosclerosis	0.00106	0.00628	CcSEcCtD
Dihydrocodeine—Pruritus—Ezetimibe—atherosclerosis	0.00106	0.00625	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00105	0.00623	CcSEcCtD
Dihydrocodeine—Diarrhoea—Lovastatin—atherosclerosis	0.00104	0.00617	CcSEcCtD
Dihydrocodeine—Urticaria—Niacin—atherosclerosis	0.00104	0.00615	CcSEcCtD
Dihydrocodeine—Abdominal pain—Niacin—atherosclerosis	0.00104	0.00612	CcSEcCtD
Dihydrocodeine—Urticaria—Pravastatin—atherosclerosis	0.00102	0.00605	CcSEcCtD
Dihydrocodeine—Diarrhoea—Ezetimibe—atherosclerosis	0.00102	0.00605	CcSEcCtD
Dihydrocodeine—Abdominal pain—Pravastatin—atherosclerosis	0.00102	0.00603	CcSEcCtD
Dihydrocodeine—Pruritus—Simvastatin—atherosclerosis	0.00101	0.00596	CcSEcCtD
Dihydrocodeine—Dizziness—Lovastatin—atherosclerosis	0.00101	0.00596	CcSEcCtD
Dihydrocodeine—Dizziness—Ezetimibe—atherosclerosis	0.000989	0.00585	CcSEcCtD
Dihydrocodeine—Diarrhoea—Simvastatin—atherosclerosis	0.000976	0.00577	CcSEcCtD
Dihydrocodeine—Vomiting—Lovastatin—atherosclerosis	0.000969	0.00573	CcSEcCtD
Dihydrocodeine—Rash—Lovastatin—atherosclerosis	0.000961	0.00568	CcSEcCtD
Dihydrocodeine—Dermatitis—Lovastatin—atherosclerosis	0.00096	0.00568	CcSEcCtD
Dihydrocodeine—Headache—Lovastatin—atherosclerosis	0.000955	0.00565	CcSEcCtD
Dihydrocodeine—Vomiting—Ezetimibe—atherosclerosis	0.000951	0.00562	CcSEcCtD
Dihydrocodeine—Dizziness—Simvastatin—atherosclerosis	0.000943	0.00557	CcSEcCtD
Dihydrocodeine—Rash—Ezetimibe—atherosclerosis	0.000943	0.00557	CcSEcCtD
Dihydrocodeine—Dermatitis—Ezetimibe—atherosclerosis	0.000942	0.00557	CcSEcCtD
Dihydrocodeine—Headache—Ezetimibe—atherosclerosis	0.000937	0.00554	CcSEcCtD
Dihydrocodeine—Pruritus—Niacin—atherosclerosis	0.000926	0.00548	CcSEcCtD
Dihydrocodeine—Pruritus—Pravastatin—atherosclerosis	0.000912	0.00539	CcSEcCtD
Dihydrocodeine—Vomiting—Simvastatin—atherosclerosis	0.000907	0.00536	CcSEcCtD
Dihydrocodeine—Nausea—Lovastatin—atherosclerosis	0.000906	0.00535	CcSEcCtD
Dihydrocodeine—Rash—Simvastatin—atherosclerosis	0.000899	0.00532	CcSEcCtD
Dihydrocodeine—Dermatitis—Simvastatin—atherosclerosis	0.000898	0.00531	CcSEcCtD
Dihydrocodeine—Diarrhoea—Niacin—atherosclerosis	0.000896	0.0053	CcSEcCtD
Dihydrocodeine—Headache—Simvastatin—atherosclerosis	0.000893	0.00528	CcSEcCtD
Dihydrocodeine—Nausea—Ezetimibe—atherosclerosis	0.000888	0.00525	CcSEcCtD
Dihydrocodeine—Diarrhoea—Pravastatin—atherosclerosis	0.000882	0.00521	CcSEcCtD
Dihydrocodeine—Dizziness—Niacin—atherosclerosis	0.000866	0.00512	CcSEcCtD
Dihydrocodeine—Dizziness—Pravastatin—atherosclerosis	0.000853	0.00504	CcSEcCtD
Dihydrocodeine—Nausea—Simvastatin—atherosclerosis	0.000847	0.00501	CcSEcCtD
Dihydrocodeine—Vomiting—Niacin—atherosclerosis	0.000833	0.00492	CcSEcCtD
Dihydrocodeine—Rash—Niacin—atherosclerosis	0.000826	0.00488	CcSEcCtD
Dihydrocodeine—Dermatitis—Niacin—atherosclerosis	0.000825	0.00488	CcSEcCtD
Dihydrocodeine—Headache—Niacin—atherosclerosis	0.00082	0.00485	CcSEcCtD
Dihydrocodeine—Vomiting—Pravastatin—atherosclerosis	0.00082	0.00485	CcSEcCtD
Dihydrocodeine—Rash—Pravastatin—atherosclerosis	0.000813	0.00481	CcSEcCtD
Dihydrocodeine—Dermatitis—Pravastatin—atherosclerosis	0.000812	0.0048	CcSEcCtD
Dihydrocodeine—Headache—Pravastatin—atherosclerosis	0.000808	0.00477	CcSEcCtD
Dihydrocodeine—Nausea—Niacin—atherosclerosis	0.000778	0.0046	CcSEcCtD
Dihydrocodeine—Nausea—Pravastatin—atherosclerosis	0.000766	0.00453	CcSEcCtD
Dihydrocodeine—OPRM1—GPCR ligand binding—UTS2—atherosclerosis	0.000129	0.00417	CbGpPWpGaD
Dihydrocodeine—OPRM1—G alpha (i) signalling events—KNG1—atherosclerosis	0.000126	0.00408	CbGpPWpGaD
Dihydrocodeine—OPRM1—Peptide ligand-binding receptors—EDN1—atherosclerosis	0.000126	0.00408	CbGpPWpGaD
Dihydrocodeine—OPRM1—Peptide ligand-binding receptors—CCL5—atherosclerosis	0.000125	0.00405	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000124	0.004	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—CX3CR1—atherosclerosis	0.000123	0.004	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—CASR—atherosclerosis	0.000123	0.004	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Melatonin metabolism and effects—NFKB1—atherosclerosis	0.000121	0.00392	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—CX3CL1—atherosclerosis	0.000121	0.00392	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—IL1B—atherosclerosis	0.000119	0.00384	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.000117	0.00379	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.000117	0.00379	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.000116	0.00377	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—CNR2—atherosclerosis	0.000115	0.00372	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.000114	0.0037	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—HRH1—atherosclerosis	0.000113	0.00366	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—NFKB1—atherosclerosis	0.000111	0.00359	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—MAPK8—atherosclerosis	0.000109	0.00352	CbGpPWpGaD
Dihydrocodeine—OPRM1—G alpha (i) signalling events—CCL5—atherosclerosis	0.000105	0.00341	CbGpPWpGaD
Dihydrocodeine—OPRM1—Peptide ligand-binding receptors—AGT—atherosclerosis	0.000104	0.00338	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—HRH1—atherosclerosis	0.000102	0.00332	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000102	0.00331	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.0001	0.00325	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	9.96e-05	0.00323	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—CCL3—atherosclerosis	9.86e-05	0.00319	CbGpPWpGaD
Dihydrocodeine—OPRM1—Peptide ligand-binding receptors—F2—atherosclerosis	9.65e-05	0.00313	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—MAPK3—atherosclerosis	9.5e-05	0.00308	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	9.43e-05	0.00306	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	9.3e-05	0.00301	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—TGFB1—atherosclerosis	9.22e-05	0.00299	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—EDNRA—atherosclerosis	8.92e-05	0.00289	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—CCR2—atherosclerosis	8.92e-05	0.00289	CbGpPWpGaD
Dihydrocodeine—OPRM1—G alpha (i) signalling events—AGT—atherosclerosis	8.81e-05	0.00286	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	8.72e-05	0.00282	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—GHRL—atherosclerosis	8.69e-05	0.00282	CbGpPWpGaD
Dihydrocodeine—OPRM1—IL4-mediated signaling events—AKT1—atherosclerosis	8.64e-05	0.0028	CbGpPWpGaD
Dihydrocodeine—OPRM1—Peptide ligand-binding receptors—CCL2—atherosclerosis	8.6e-05	0.00279	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	8.6e-05	0.00279	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	8.44e-05	0.00274	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	8.38e-05	0.00271	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—KNG1—atherosclerosis	7.63e-05	0.00247	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—AGTR1—atherosclerosis	7.58e-05	0.00246	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CCL4—atherosclerosis	7.41e-05	0.0024	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—UTS2—atherosclerosis	7.27e-05	0.00236	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	7.01e-05	0.00227	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—CASR—atherosclerosis	6.97e-05	0.00226	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—IL6—atherosclerosis	6.95e-05	0.00225	CbGpPWpGaD
Dihydrocodeine—OPRM1—Peptide ligand-binding receptors—CXCL8—atherosclerosis	6.8e-05	0.0022	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—UTS2—atherosclerosis	6.6e-05	0.00214	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—CNR2—atherosclerosis	6.48e-05	0.0021	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	6.48e-05	0.0021	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—EDN1—atherosclerosis	6.43e-05	0.00208	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—AKT1—atherosclerosis	6.41e-05	0.00208	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—CCL5—atherosclerosis	6.38e-05	0.00207	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CX3CR1—atherosclerosis	6.33e-05	0.00205	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CASR—atherosclerosis	6.33e-05	0.00205	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CX3CL1—atherosclerosis	6.21e-05	0.00201	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HRH1—atherosclerosis	6.05e-05	0.00196	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—GSTM1—atherosclerosis	5.96e-05	0.00193	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CNR2—atherosclerosis	5.89e-05	0.00191	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—GSTM1—atherosclerosis	5.87e-05	0.0019	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	5.77e-05	0.00187	CbGpPWpGaD
Dihydrocodeine—OPRM1—G alpha (i) signalling events—CXCL8—atherosclerosis	5.74e-05	0.00186	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—AGT—atherosclerosis	5.34e-05	0.00173	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CCL3—atherosclerosis	5.06e-05	0.00164	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—CCR2—atherosclerosis	5.04e-05	0.00163	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—EDNRA—atherosclerosis	5.04e-05	0.00163	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—F2—atherosclerosis	4.93e-05	0.0016	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—GHRL—atherosclerosis	4.91e-05	0.00159	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—APOA4—atherosclerosis	4.75e-05	0.00154	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CCR2—atherosclerosis	4.58e-05	0.00148	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—EDNRA—atherosclerosis	4.58e-05	0.00148	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	4.56e-05	0.00148	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—GHRL—atherosclerosis	4.46e-05	0.00144	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—CCL2—atherosclerosis	4.39e-05	0.00142	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CCL4—atherosclerosis	4.38e-05	0.00142	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—KNG1—atherosclerosis	4.31e-05	0.0014	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—AGTR1—atherosclerosis	4.29e-05	0.00139	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—LDLRAP1—atherosclerosis	4.22e-05	0.00137	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—APOA2—atherosclerosis	4.09e-05	0.00132	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PLTP—atherosclerosis	3.97e-05	0.00129	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—KNG1—atherosclerosis	3.92e-05	0.00127	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—UTS2—atherosclerosis	3.9e-05	0.00126	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	3.89e-05	0.00126	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—AGTR1—atherosclerosis	3.89e-05	0.00126	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	3.84e-05	0.00124	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CX3CR1—atherosclerosis	3.74e-05	0.00121	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CASR—atherosclerosis	3.74e-05	0.00121	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CX3CL1—atherosclerosis	3.67e-05	0.00119	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—EDN1—atherosclerosis	3.63e-05	0.00118	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—CCL5—atherosclerosis	3.61e-05	0.00117	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CNR2—atherosclerosis	3.48e-05	0.00113	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—CXCL8—atherosclerosis	3.47e-05	0.00113	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—MMP3—atherosclerosis	3.47e-05	0.00112	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—LTA4H—atherosclerosis	3.44e-05	0.00112	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ABCG8—atherosclerosis	3.44e-05	0.00112	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PRKCG—atherosclerosis	3.43e-05	0.00111	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—EDN1—atherosclerosis	3.3e-05	0.00107	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CCL5—atherosclerosis	3.27e-05	0.00106	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PRKCG—atherosclerosis	3.11e-05	0.00101	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—VWF—atherosclerosis	3.1e-05	0.001	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—APOC3—atherosclerosis	3.08e-05	0.000998	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—LDLR—atherosclerosis	3.06e-05	0.000992	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—AGT—atherosclerosis	3.02e-05	0.000977	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CCL3—atherosclerosis	2.99e-05	0.000969	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NCF1—atherosclerosis	2.86e-05	0.000928	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—F2—atherosclerosis	2.79e-05	0.000903	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.76e-05	0.000894	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—AGT—atherosclerosis	2.74e-05	0.000887	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ABCG1—atherosclerosis	2.72e-05	0.000882	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CCR2—atherosclerosis	2.7e-05	0.000876	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EDNRA—atherosclerosis	2.7e-05	0.000876	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CYBA—atherosclerosis	2.69e-05	0.000872	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	2.67e-05	0.000864	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PLAT—atherosclerosis	2.63e-05	0.000854	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PARP1—atherosclerosis	2.63e-05	0.000854	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GHRL—atherosclerosis	2.63e-05	0.000854	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PLTP—atherosclerosis	2.6e-05	0.000841	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—FABP4—atherosclerosis	2.56e-05	0.000829	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—LCAT—atherosclerosis	2.56e-05	0.000829	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—F2—atherosclerosis	2.53e-05	0.00082	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—APOA4—atherosclerosis	2.51e-05	0.000814	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP7A1—atherosclerosis	2.47e-05	0.000799	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CG—atherosclerosis	2.42e-05	0.000785	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—KNG1—atherosclerosis	2.31e-05	0.000749	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AGTR1—atherosclerosis	2.3e-05	0.000745	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP27A1—atherosclerosis	2.28e-05	0.000739	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CCL2—atherosclerosis	2.26e-05	0.000731	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.25e-05	0.000729	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.25e-05	0.000729	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PLG—atherosclerosis	2.24e-05	0.000726	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	2.16e-05	0.0007	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—APOA2—atherosclerosis	2.16e-05	0.0007	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	2.16e-05	0.0007	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ALOX15—atherosclerosis	2.16e-05	0.0007	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ABCG5—atherosclerosis	2.14e-05	0.000692	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SOCS3—atherosclerosis	2.12e-05	0.000687	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—LPA—atherosclerosis	2.06e-05	0.000668	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MMP3—atherosclerosis	2.05e-05	0.000664	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IGF2—atherosclerosis	2.04e-05	0.000661	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—BGN—atherosclerosis	2e-05	0.000647	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—APOB—atherosclerosis	1.98e-05	0.000642	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—APOA5—atherosclerosis	1.98e-05	0.000641	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—CXCL8—atherosclerosis	1.96e-05	0.000636	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EDN1—atherosclerosis	1.95e-05	0.000631	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CCL5—atherosclerosis	1.93e-05	0.000627	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.9e-05	0.000617	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—LPL—atherosclerosis	1.89e-05	0.000613	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PRKCG—atherosclerosis	1.84e-05	0.000596	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.84e-05	0.000595	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SPP1—atherosclerosis	1.79e-05	0.00058	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CXCL8—atherosclerosis	1.78e-05	0.000578	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.78e-05	0.000576	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—FABP4—atherosclerosis	1.67e-05	0.000542	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—LCAT—atherosclerosis	1.67e-05	0.000542	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PDGFB—atherosclerosis	1.66e-05	0.000537	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.65e-05	0.000534	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—APOA4—atherosclerosis	1.64e-05	0.000532	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—LIPC—atherosclerosis	1.64e-05	0.000531	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—APOC3—atherosclerosis	1.63e-05	0.000527	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—LDLR—atherosclerosis	1.62e-05	0.000524	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AGT—atherosclerosis	1.62e-05	0.000524	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.61e-05	0.000523	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—LEP—atherosclerosis	1.59e-05	0.000514	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—APOE—atherosclerosis	1.59e-05	0.000514	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CETP—atherosclerosis	1.58e-05	0.000512	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CAV1—atherosclerosis	1.57e-05	0.000509	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—APOA1—atherosclerosis	1.57e-05	0.000508	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.51e-05	0.00049	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ESR1—atherosclerosis	1.51e-05	0.00049	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—F2—atherosclerosis	1.49e-05	0.000484	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.49e-05	0.000483	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CG—atherosclerosis	1.43e-05	0.000463	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.43e-05	0.000463	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.41e-05	0.000458	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.41e-05	0.000458	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.41e-05	0.000458	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—APOA2—atherosclerosis	1.41e-05	0.000458	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.4e-05	0.000452	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—MAPK3—atherosclerosis	1.37e-05	0.000444	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—INS—atherosclerosis	1.35e-05	0.000439	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—LPA—atherosclerosis	1.35e-05	0.000437	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CCL2—atherosclerosis	1.33e-05	0.000432	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IGF1—atherosclerosis	1.31e-05	0.000424	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—BGN—atherosclerosis	1.31e-05	0.000423	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—APOA5—atherosclerosis	1.29e-05	0.000419	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.27e-05	0.000413	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.24e-05	0.000403	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SERPINE1—atherosclerosis	1.24e-05	0.000403	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.2e-05	0.000389	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NOS3—atherosclerosis	1.19e-05	0.000385	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.09e-05	0.000354	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.08e-05	0.000349	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—LIPC—atherosclerosis	1.07e-05	0.000347	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—APOC3—atherosclerosis	1.06e-05	0.000345	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—LDLR—atherosclerosis	1.06e-05	0.000343	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CXCL8—atherosclerosis	1.05e-05	0.000341	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—APOB—atherosclerosis	1.05e-05	0.000339	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CETP—atherosclerosis	1.03e-05	0.000335	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.02e-05	0.00033	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—AKT1—atherosclerosis	1.02e-05	0.00033	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—IL6—atherosclerosis	1e-05	0.000324	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—LPL—atherosclerosis	1e-05	0.000324	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SCARB1—atherosclerosis	9.9e-06	0.000321	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GPX1—atherosclerosis	9.75e-06	0.000316	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MMP9—atherosclerosis	9.53e-06	0.000309	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CD36—atherosclerosis	9.5e-06	0.000308	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NFKB1—atherosclerosis	9.43e-06	0.000305	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HMGCR—atherosclerosis	9.35e-06	0.000303	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MAPK8—atherosclerosis	9.27e-06	0.0003	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—AKT1—atherosclerosis	9.24e-06	0.000299	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—MTHFR—atherosclerosis	9e-06	0.000292	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PPARA—atherosclerosis	8.83e-06	0.000286	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—VEGFA—atherosclerosis	8.56e-06	0.000277	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—AGT—atherosclerosis	8.55e-06	0.000277	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—STAT3—atherosclerosis	8.47e-06	0.000274	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—APOE—atherosclerosis	8.38e-06	0.000271	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ABCA1—atherosclerosis	8.33e-06	0.00027	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CAV1—atherosclerosis	8.3e-06	0.000269	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—APOA1—atherosclerosis	8.28e-06	0.000268	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MAPK3—atherosclerosis	8.09e-06	0.000262	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TGFB1—atherosclerosis	7.85e-06	0.000254	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	7.56e-06	0.000245	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PPARG—atherosclerosis	7.3e-06	0.000236	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—INS—atherosclerosis	7.16e-06	0.000232	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HMOX1—atherosclerosis	7.15e-06	0.000232	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—APOB—atherosclerosis	6.85e-06	0.000222	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTM1—atherosclerosis	6.66e-06	0.000216	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ALB—atherosclerosis	6.56e-06	0.000213	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—LPL—atherosclerosis	6.54e-06	0.000212	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GPX1—atherosclerosis	6.38e-06	0.000207	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NOS3—atherosclerosis	6.28e-06	0.000203	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CD36—atherosclerosis	6.21e-06	0.000201	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IL6—atherosclerosis	5.92e-06	0.000192	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MTHFR—atherosclerosis	5.89e-06	0.000191	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PPARA—atherosclerosis	5.77e-06	0.000187	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PTGS2—atherosclerosis	5.74e-06	0.000186	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—AGT—atherosclerosis	5.59e-06	0.000181	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—APOE—atherosclerosis	5.48e-06	0.000177	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AKT1—atherosclerosis	5.46e-06	0.000177	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CAV1—atherosclerosis	5.43e-06	0.000176	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—APOA1—atherosclerosis	5.42e-06	0.000175	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.94e-06	0.00016	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PPARG—atherosclerosis	4.77e-06	0.000155	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—INS—atherosclerosis	4.68e-06	0.000152	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ALB—atherosclerosis	4.29e-06	0.000139	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NOS3—atherosclerosis	4.1e-06	0.000133	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.75e-06	0.000122	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—AKT1—atherosclerosis	2.89e-06	9.35e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.89e-06	6.11e-05	CbGpPWpGaD
